Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6018024
SERIAL NO

08846444

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Processing of .beta.-amyloid precursor protein (.beta.APP) is monitored by detecting the secretion of a soluble .beta.APP fragment resulting from cleavage of .beta.APP at the amino-terminus of .beta.-amyloid peptide. In vivo monitoring of secretion of the .beta.APP fragment may be monitored for diagnosis and prognosis of Alzheimer's disease and other .beta.-amyloid-related diseases, while in vitro monitoring of such secretion from cultured cells may be monitored to identify inhibitors of .beta.-amyloid production. The .beta.APP fragment may be detected using antibodies and other specific binding substances which recognize a carboxy-terminal residue on the fragment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ELAN PHARMACEUTICALS, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fritz, Lawrence C San Francisco, CA 25 535
Schenk, Dale B Pacifica, CA 133 5593
Seubert, Peter A South San Francisco, CA 33 1389

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation